Portfolio company
Early
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Early develops home diagnostic devices for patients to screen for biomarkers and monitor conditions like kidney disease and cardiovascular disease from their own home.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Everly Health
This company provides at-home diagnostic lab tests and telehealth services for individual consumers, health plans and employers to monitor diverse health conditions.
KidneyMetrix
The company develops an artificial intelligence platform using non-invasive sampling to provide early diagnostic insights for kidney injuries to healthcare providers.
EarlySight
EarlySight develops a cellular-level retinal imaging camera and AI software for eye doctors to detect and monitor ophthalmic diseases at microscopic scales.
Aptatek Biosciences
This company develops portable diagnostic devices for home monitoring of biomarkers to help patients manage chronic conditions such as phenylketonuria.
Nephrolyx
Nephrolyx develops diagnostic test kits and a digital platform for precise kidney function measurement to help clinicians and laboratories detect renal diseases.
SpotItEarly
The company develops an artificial intelligence and canine-based breath test for early cancer screening in individuals and high-risk groups.
Auvi Labs
This company develops a wearable ultrasound patch to monitor dialysis access and detect potential fistula failure for patients and clinicians.
Entia
This company develops at-home blood monitoring devices for cancer patients to share results with healthcare providers and improve treatment management.
